Actively Recruiting
Food Intervention to Reduce Immunotherapy ToXicity
Led by Universitair Ziekenhuis Brussel · Updated on 2025-03-26
60
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The FORX (Food intervention to Reduce immunotherapy toXicity) trial will assess whether supplementing dietary fiber intake by providing weekly boxes containing 30 different plants to patients with solid tumors starting immune checkpoint inhibitor therapy affects the incidence of immune related adverse events.
CONDITIONS
Official Title
Food Intervention to Reduce Immunotherapy ToXicity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Solid tumor starting anti-programmed cell death protein 1 (anti-PD1) and/or anti-cytotoxic T-lymphocyte-associated antigen 4 (anti-CTLA4) antibodies as part of standard of care
- Able to sign informed consent
You will not qualify if you...
- No oral intake possible
- Probiotic use and unwillingness to stop during the trial
- Combination therapy with chemotherapy or targeted agents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Brussel
Jette, Belgium, 1090
Actively Recruiting
Research Team
M
Marthe Verhaert, MD
CONTACT
S
Sandrine Aspeslagh, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here